Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine H Smith

Showing results (31-40 of 169) with videos related to

Pageof 17
Sort By:
The Journal of Investigative Dermatology|June 25, 2013
Loss of IL36RN function does not confer susceptibility to psoriasis vulgarisDorottya M Berki, Satveer K Mahil, A David Burden, et al.
The Journal of Investigative Dermatology|August 7, 2017
Obesity, Waist Circumference, Weight Change, and Risk of Incident Psoriasis: Prospective Data from the HUNT StudyIngrid Snekvik, Catherine H Smith, Tom I L Nilsen, et al.
The British Journal of Dermatology|January 10, 2025
Age and biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)Oras A Alabas, Kayleigh J Mason, Zenas Z N Yiu, et al.
Journal of Pediatric Hematology/Oncology|May 9, 2014
Patient-centered approach to designing sickle cell transition educationCourtney P Williams, Catherine H Smith, Kristen Osborn, et al.
The Journal of Investigative Dermatology|July 2, 2025
Response to Lavin et al (2025)'s Paper: Cutaneous T-Cell Lymphoma after Dupilumab Use: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting SystemMariel L James, Andrew E Pink, Richard T Woolf, et al.
The British Journal of Dermatology|January 30, 2023
Are Janus kinase inhibitors an effective treatment for palmoplantar pustulosis? A critically appraised topicDavid Gleeson, Jonathan N W N Barker, Francesca Capon, et al.
American Journal of Perinatology|July 30, 2021
Care of the Postpartum Patient in the Emergency Department: A Systematic Review with Implications for Maternal MortalityKellie A Mitchell, Alison J Haddock, Hamad Husainy, et al.
Clinical Epidemiology|August 14, 2023
Anxiety and Depression in People with Eczema or Psoriasis: A Comparison of Associations in UK Biobank and Linked Primary Care DataJulian Matthewman, Kathryn E Mansfield, Joseph F Hayes, et al.
The British Journal of Dermatology|May 25, 2023
Effectiveness and survival of methotrexate versus adalimumab in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)Oras A Alabas, Kayleigh J Mason, Zenas Z N Yiu, et al.
JAMA Dermatology|July 6, 2022
Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With PsoriasisZenas Z N Yiu, Gabrielle Becher, Brian Kirby, et al.
Pageof 17

Showing results (31-40 of 169) with videos related to

Sort By:
Pageof 17
The Journal of Investigative Dermatology|June 25, 2013
Loss of IL36RN function does not confer susceptibility to psoriasis vulgarisDorottya M Berki, Satveer K Mahil, A David Burden, et al.
The Journal of Investigative Dermatology|August 7, 2017
Obesity, Waist Circumference, Weight Change, and Risk of Incident Psoriasis: Prospective Data from the HUNT StudyIngrid Snekvik, Catherine H Smith, Tom I L Nilsen, et al.
The British Journal of Dermatology|January 10, 2025
Age and biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)Oras A Alabas, Kayleigh J Mason, Zenas Z N Yiu, et al.
Journal of Pediatric Hematology/Oncology|May 9, 2014
Patient-centered approach to designing sickle cell transition educationCourtney P Williams, Catherine H Smith, Kristen Osborn, et al.
The Journal of Investigative Dermatology|July 2, 2025
Response to Lavin et al (2025)'s Paper: Cutaneous T-Cell Lymphoma after Dupilumab Use: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting SystemMariel L James, Andrew E Pink, Richard T Woolf, et al.
The British Journal of Dermatology|January 30, 2023
Are Janus kinase inhibitors an effective treatment for palmoplantar pustulosis? A critically appraised topicDavid Gleeson, Jonathan N W N Barker, Francesca Capon, et al.
American Journal of Perinatology|July 30, 2021
Care of the Postpartum Patient in the Emergency Department: A Systematic Review with Implications for Maternal MortalityKellie A Mitchell, Alison J Haddock, Hamad Husainy, et al.
Clinical Epidemiology|August 14, 2023
Anxiety and Depression in People with Eczema or Psoriasis: A Comparison of Associations in UK Biobank and Linked Primary Care DataJulian Matthewman, Kathryn E Mansfield, Joseph F Hayes, et al.
The British Journal of Dermatology|May 25, 2023
Effectiveness and survival of methotrexate versus adalimumab in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)Oras A Alabas, Kayleigh J Mason, Zenas Z N Yiu, et al.
JAMA Dermatology|July 6, 2022
Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With PsoriasisZenas Z N Yiu, Gabrielle Becher, Brian Kirby, et al.
Pageof 17